Vimarsana
Biggest News Aggregation in the World

Page 43 - Wave Life Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Wave Life Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Wave Life Sciences Today - Breaking & Trending Today

Wave Life Sciences: Q1 Earnings Snapshot - Vimarsana News

Wave Life Sciences: Q1 Earnings Snapshot

Wave Life Sciences: Q1 Earnings Snapshot by The Associated Press Last Updated May 13, 2021 at 8:14 am EDT SINGAPORE (AP) _ Wave Life Sciences Pte. Ltd. (WVE) on Thursday reported a loss of $42.5 million in its first quarter. The Singapore-based company said it had a loss of 86 cents per share. The results missed Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 56 cents per share. Wave Life Sciences shares have dropped 22% since the beginning of the year. The stock has fallen 40% in the last 12 months. _____ This story was ...

Huntington's disease setback for Roche shifts the research spotlight to Prilenia - Vimarsana News

Huntington's disease setback for Roche shifts the research spotlight to Prilenia

Video Blog Blog Blog 11 May, 2021 Author Etain Lavelle Huntington's disease research suffered a double whammy after Swiss pharmaceutical giant Roche Holding AG halted late-stage trials of an experimental medicine and Wave Life Sciences Ltd. abandoned two drug studies for futility. Roche stopped dosing patients with tominersen after an independent data monitoring committee questioned whether the drug's benefits outweighed its risks. "Obviously, it's a very sad situation when we have to stop a pivotal program in a disease like Huntington's where the...

The ALS Association Massachusetts Chapter Hosts Inaugural - Vimarsana News

The ALS Association Massachusetts Chapter Hosts Inaugural

The ALS Association Massachusetts Chapter Hosts Inaugural “CEO Soak” on June 10 in Downtown Boston Event Builds on Ice Bucket Challenge Legacy to Raise Funds for Local Families Living with ALS The ALS Association Massachusetts Chapter Norwood, Massachusetts, UNITED STATES NORWOOD, Mass., May 11, 2021 (GLOBE NEWSWIRE) -- The ALS Association Massachusetts Chapter is encouraging local leadership to get soaked for a great cause. On Thursday, June 10, the organization will host its first-ever CEO Soak at Rings Fountain on the Rose Kennedy Greenway in downtown Boston, w...

Failure of Genetic Therapies for Huntington's Devastates Community - Vimarsana News

Failure of Genetic Therapies for Huntington's Devastates Community

Scientific American Hopes were high for drugs designed to lower levels of a mutant protein, but development has stalled orange  Advertisement Two pharmaceutical companies have halted clinical trials of gene-targeting therapies for Huntington’s disease (HD), following the drugs’ disappointing performance. Researchers had hoped that the treatments—known as antisense oligonucleotides (ASOs)—would be a game changer for HD, an incurable genetic condition that affects cognition, behaviour and movement. But back-to-back announcements from Roche, headquartered in Basel, Switzerland, and Wave...

DMD | Benzinga - Vimarsana News

DMD | Benzinga

Just weeks into its life as a publicly traded company, Solid Biosciences Inc (NASDAQ: SLDB) caught the eyes of four analysts who assumed coverage Tuesday with a mix of Holds and Buys. Here is what one of the more bearish critics had to say. The Rating Goldman Sachs analyst Salveen Richter... Read More...